Author name: Dean Silver, M.D.

Understanding your pathology report is one of the most important steps after a cancer diagnosis. This report identifies the type

Immunotherapy biomarkers help oncologists estimate whether a cancer may respond to immune checkpoint inhibitors. The three markers’ patients see most

A multi-cancer early detection test is designed to look for signals from many different cancers from a single blood draw.

Lifestyle during cancer treatment is no longer simply about feeling better. Exercise, nutrition, metabolic health, sleep, and psychological support can

Root cause testing for cancer looks for measurable factors that may have contributed to cancer risk, immune dysfunction, chronic inflammation,

Cancer pathway mapping can turn a complicated genomic report into something much easier to understand. A comprehensive tumor report may

By Dr. Dean Silver, MD, MD (H) Circulating tumor cells are intact cancer cells that have detached from a tumor

By Dr. Dean Silver, MD, MD (H) ctDNA monitoring offers another source of information. For many patients, one of the

By Dean R. Silver, MD, MD(H) Tissue biopsy vs liquid biopsy is not really a question of which test is

Comprehensive tumor profiling can reveal information about a cancer that may not be visible under a microscope or detected by